"Iodine-131 Uptake Study", StatPearls , Treasure Island (FL): StatPearls Publishing, PMID 32644709, retrieved 30 November 2025 1 2 "Vol 8 Issue 4 p.11"
The trial included 3297 patients receiving either once-weekly semaglutide or placebo over 104 weeks
These include the following: Medullary carcinoma of thyroid (MTC) and Multiple Endocrine Neoplasia type 2 syndrome (MEN 2): Semaglutide is contraindicated in patients with a personal or family history of thyroid tumors, particularly medullary thyroid carcinoma (MTC) and Multiple Endocrine Neoplasia type 2 syndrome (MEN 2)
This is the first and only oral form of semaglutide, available as a once-daily tablet
The compound is supplied as a lyophilized white-to-off-white powder in a sealed amber-glass vial under inert gas
4,5 A recent large cohort study of U.S